Wellington Management Group’s Praxis Precision Medicines PRAX Stock Holding History

Wellington Management Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.2M	Sell	174,350 -2,212	-1%	-$684K	0.01%	703
2025 Q4	$52M	Buy	176,562 +115,321	+188%	+$21.5M	0.01%	728
2025 Q3	$3.25M	Buy	61,241 +5,360	+10%	+$260K	﹤0.01%	1526
2025 Q2	$2.35M	Buy	55,881 +5,105	+10%	+$194K	﹤0.01%	1537
2025 Q1	$1.92M	Sell	50,776 -13,158	-21%	-$822K	﹤0.01%	1569
2024 Q4	$4.92M	Sell	63,934 -155,973	-71%	-$11.3M	﹤0.01%	1353
2024 Q3	$12.7M	Buy	219,907 +168,394	+327%	+$9.1M	﹤0.01%	1101
2024 Q2	$2.13M	Buy	51,513 +11,948	+30%	+$565K	﹤0.01%	1501
2024 Q1	$2.41M	Buy	+39,565	New	+$1.77M	﹤0.01%	1481

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group's PRAX Position: Q1 2026 in Review

Wellington Management Group reduced its Praxis Precision Medicines (PRAX) stake by 1.3% in Q1 2026, selling an estimated $684K and leaving 174,350 shares worth $56.2M. The position accounts for 0.01% of the portfolio, ranked #703.

Wellington Management Group first reported a position in PRAX in Q1 2024 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Wellington Management Group held 174,350 shares of Praxis Precision Medicines worth $56.2M as of Q1 2026.
Wellington Management Group sold 2,212 Praxis Precision Medicines shares in Q1 2026, an estimated $684K.
Praxis Precision Medicines made up 0.01% of Wellington Management Group's portfolio in Q1 2026, its #703 holding.
Wellington Management Group first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 9 quarters since.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.